These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 9457961)
1. The mother lode of liver transplantation, with particular reference to our new journal. Starzl TE Liver Transpl Surg; 1998 Jan; 4(1):1-14. PubMed ID: 9457961 [No Abstract] [Full Text] [Related]
3. [Four decades since the beginning of Experimental Gastroenterological Surgery at the Peruvian University]. Baracco Gandolfo V Rev Gastroenterol Peru; 1995; 15 Suppl 1():S121-8. PubMed ID: 8520016 [TBL] [Abstract][Full Text] [Related]
4. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Starzl TE; Nalesnik MA; Porter KA; Ho M; Iwatsuki S; Griffith BP; Rosenthal JT; Hakala TR; Shaw BW; Hardesty RL Lancet; 1984 Mar; 1(8377):583-7. PubMed ID: 6142304 [TBL] [Abstract][Full Text] [Related]
6. The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). Starzl TE J Am Coll Surg; 2002 Nov; 195(5):587-610. PubMed ID: 12437245 [No Abstract] [Full Text] [Related]
7. Early history of the portacaval shunt in humans. Donovan AJ; Covey PC Surg Gynecol Obstet; 1978 Sep; 147(3):423-30. PubMed ID: 356307 [No Abstract] [Full Text] [Related]
8. Post-transplant lymphoproliferative disorders in a cohort of adult patients with a liver transplant from a reference hospital in Bogotá, Colombia. Jurado LF; Gómez-Aldana A; Tapias M; Cáceres D; Vera A; López-Panqueva RDP; Andrade RE Biomedica; 2020 Sep; 40(3):498-506. PubMed ID: 33030828 [TBL] [Abstract][Full Text] [Related]
9. Post-transplant malignancies in pediatric liver transplant recipients: Experience of two centers in Turkey. Karakoyun M; Önen Ş; Baran M; Çakır M; Ömür Ecevit Ç; Kılıç M; Kantar M; Aksoylar S; Özgenç F; Aydoğdu S Turk J Gastroenterol; 2018 Jan; 29(1):89-93. PubMed ID: 29391313 [TBL] [Abstract][Full Text] [Related]
10. Presidential address: reflections on the early development of portacaval shunts. Warren WD Ann Surg; 1980 May; 191(5):519-27. PubMed ID: 6989329 [No Abstract] [Full Text] [Related]
11. [Diagnosis and treatment of de novo malignancy after liver transplantation]. Zhu ZJ; Li L; Zhang YM Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):237-8. PubMed ID: 17649647 [No Abstract] [Full Text] [Related]
12. Chapter 6.6. The Role of ESPGHAN in Developing Effective Immunosuppression Following Paediatric Liver Transplantation. Kelly D J Pediatr Gastroenterol Nutr; 2018 Apr; 66 Suppl 1():S142-S143. PubMed ID: 29596187 [No Abstract] [Full Text] [Related]
13. Withdrawal of immunosuppression in liver transplantation: lessons learned from PTLD. Mazariegos GV Pediatr Transplant; 2004 Jun; 8(3):210-3. PubMed ID: 15176955 [No Abstract] [Full Text] [Related]
14. [On the centenary of the portacaval anastomosis operation]. Epifanov NS Klin Med (Mosk); 1977 Aug; (8):145-7. PubMed ID: 333173 [No Abstract] [Full Text] [Related]
15. Introduction to Special Issue on Liver Transplant and HCC at Inonu University, Turkey. Yilmaz S; Carr BI J Gastrointest Cancer; 2020 Dec; 51(4):1103. PubMed ID: 32851545 [No Abstract] [Full Text] [Related]
16. [Surgical methods of treating portal hypertension with ascites (on the centenary of the creation by N.V. Ekk of the 1st portacaval anastomosis in the world)]. Zubarev PN Vestn Khir Im I I Grek; 1978 May; 120(5):130-6. PubMed ID: 351919 [No Abstract] [Full Text] [Related]
18. Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Reyes J; Tzakis A; Green M; Nour B; Nalesnik M; Van Thiel D; Martin M; Breinig MK; Fung JJ; Cooper M Transplant Proc; 1991 Dec; 23(6):3044-6. PubMed ID: 1721355 [No Abstract] [Full Text] [Related]